Purchase Order 75N95023P00877

Award Date 8/11/23
Potential Completion Date 8/10/24
Potential Value $21K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St Peters, MO 63304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $45,365 firm-fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The contract is for the analysis of three compounds in a panel of 50 customized cancer cell lines over a three-month period. The work aims to evaluate the effects of the compounds on cell proliferation, cell death, caspase activity, and...
This is a $541,498.00 firm fixed-price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The contract provides nonclinical services in support of the development of interventional agents, and is issued under the Nonclinical Services for Development of Interventional Agents indefinite delivery,...
This is a $142,193 cost-plus-fixed-fee task order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The task order is for receptor binding and predictive toxicology services to support drug discovery research, with a period of performance from September 26, 2023 to September 25, 2024. Eurofins...
This is a firm fixed-price delivery order issued by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $359,131 order is for a 1-year period of performance from September 30, 2020 to September 29, 2021 under the NIDA N01DA-18-8937 contract vehicle. The work involves receptor binding and predictive toxicology services to support NIDA's drug...
This is a $7,245.40 firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the Department of Health and Human Services, to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The contract is for "OTHER FUNCTIONS - TARGET SCREENING FOR COMPOUNDS," with a period of performance ending on July 7, 2014. This contract is not designated as a small business set-aside. Eurofins...
This is a firm fixed price delivery order issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse, to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $224,328 task order is for receptor binding and predictive toxicology services under an existing indefinite delivery/indefinite quantity (IDIQ) contract, HHSN271201800024I. No set-aside was used. Eurofins Panlabs has a history of...
This is a firm-fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the Department of Health and Human Services, to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract has a total ceiling value of $659,400.00 and a period of performance through September 11, 2024. It was issued under the NIAID's "Nonclinical Services for Development of Interventional Agents"...
This is a $207,360 firm fixed price delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc. to provide non-GLP standard, initial profiling of lead compounds in rodent pharmacokinetics screening assays. The work supports the selection of promising lead series and in vitro-in vivo correlation data for the development of interventional agents. This delivery order is under the NIH's Nonclinical...
This is a firm fixed price purchase order contract awarded by the Department of the Army Medical Command to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $133,690 contract provides scientific and technical services in the form of broad panel screening, including confirmatory testing, safety evaluation, receptor binding studies, predictive toxicology, and other non-clinical research and laboratory analysis. The work supports research programs across...
This is a firm-fixed-price Delivery Order contract awarded to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $67,783 contract provides lead identification, development, chemistry, and synthesis services to support the NIAID's research and development programs. The contract is part of the NIAID's larger Nonclinical Services for...

This is a firm-fixed-price purchase order worth $20,979.04 awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract is for binding studies with a period of performance through August 10, 2024. Eurofins Panlabs has received numerous federal contract awards from agencies like NIH, EPA, FDA, and VA to provide analytical chemistry, microbiology, and toxicology testing services to support research programs. The company also holds several significant federal contract indefinite delivery vehicles (IDVs) with NCATS, NIH's National Institute on Drug Abuse, and the EPA for a range of research and development services. This award does not have a set-aside designation.

Generated 10/10/24, 9:08 AM